Not Selling Family Silver, Have Clear Divestment Strategy: Nirmala Sitharaman
Rejecting the Opposition's charge of ''selling family silver'', Finance Minister Nirmala Sitharaman on Sunday said the government has devised a clear strategy on divestment for the first time so that taxpayers' money is spent wisely. She also said the government wants few public sector enterprises in specified sectors to do well, so that we can ensure that tax payer money is spent wisely.
"It is not what the Opposition says about selling family silver, it's not at all," she said addressing a meeting of business people here.
The finance minister added, "Family silver should be strengthened, it should be our takat (strength)... Because you've spread it so thinly, there are many of them (PSUs) that are not able to survive; and the few that can perform do not get the due attention."
She also said the government's aim is to prime them through this policy. "You need them, you need them to scale up so that they meet the aspirations of growing India."
At the same event, Hindustan Unilever Chairman and Managing Director Sanjiv Mehta said the Budget 2021 is India's version of the "new deal" by focusing on relief, recovery and reform, and represents a "confident and unapologetic India".
Efforts have been undertaken to address the trust deficit between business and the government through steps such as limiting tax assessments, and the enterprises have to now respond by complying.
BSE Chief Executive Officer Ashishkumar Chauhan said the only parallel for the Budget is with the 1991 reforms document presented by then finance minister Manmohan Singh.
He also underlined the newest proposals as significant because they are not being undertaken under any duress.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.